Funding for this research was provided by:
Wellcome Trust (107469/Z/15/Z)
British Heart Foundation (SP/10/10/28431)
Fondation Leducq (11 CVD-01)
Department of Health (HICF-R6-373)
Italian Ministry of Health (RF-2013-02356787, NET-2011-02347173)
Received: 26 November 2018
Accepted: 14 January 2019
First Online: 29 January 2019
Ethics approval and consent to participate
: This study was based on previously published clinical genetics sequencing data from the OMGL and LMM laboratories. For the prospective HCM cohort from the Royal Brompton Hospital London, all patients provided written informed consent and the study was approved by the regional ethics committee. The research in this study conformed to the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.